NCT05494697 2025-10-14Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPCAIM ImmunoTech Inc.Phase 2 Suspended90 enrolled
NCT00536770 2007-11-06A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerNovaceaPhase 2 Suspended132 enrolled